Law Firms

Solutions that help deliver expertise, scalability, and cost-savings to your clients and IP practice.

Corporate Legal Departments

Supporting innovating companies with patent intelligence, tools and resources to drive commercial success.

Corporate R&D Centers

Solutions that help identify, prepare and convert new and emerging opportunities into market leading products.

Government & Academia

Helping government agencies and universities evaluate the patent landscape and identify future trends.

Chemical

The intelligence and insight chemical companies need to innovate with confidence.

Pharma & Biotech

Industry specific intelligence and insight that pharma and biotech companies need to innovate with confidence.

Events & Webinars

IP live and on-demand webinars and events, from patent experts

News

News from Derwent

Blog

Relevant articles and insight into Derwent products and the IP world

Learning

All the resources you need to answer your questions, learn new tricks, and explore Derwent

Derwent Innovation Login exit_to_app

Investors

What we do
Products & Services
Executive Leadership
Customer Delight
Sustainability
Clarivate Home

GENESEQ

Comprehensive, curated and annotated biological sequences.

Request a demo

GENESEQ™ is a proprietary database used to easily search and identify biological sequences (DNA, RNA and protein sequences) covered in patents from 56 issuing authorities. Manually annotated to highlight IP context and biological significance, GENESEQ™ allows IP professionals and biologic scientists to spend less time searching and understanding sequence data and easily assess patentability, identify potential infringing patents and track competitor activities.

Find biological sequences not available in other databases
Easily survey the sequence patent landscape
Establish freedom to operate and patentability
Quickly assess the context of the sequence in the patent
Reveal potential patent infringements
Identify prior art

Download fact sheet

GENESEQ supports IP and life sciences professionals:

Bioinformatics specialists

Molecular biologists

Licensing and business development professionals

IP professionals

Worldwide coverage of biological sequences

0 M

Biological sequences

0 K

Unique patents

Unique patents added every two weeks

Global patent authorities including WO, US, EP, JP, DE, IN, KR, and CN

Find context faster with annotated analysis

GENESEQ’s expert editorial team provides written summaries that clarify and explain sequence novelty and the actual utility of a given sequence, including:

Enhanced patent titles
Record detail includes organism name, gene/protein name, sequence modification or other highlighted biologically significant regions of the sequence, and associated disease information
Sequence location within the patent document
Standardized, full bibliographic data
Links to identical records from NCBI and SWISSPROT, Gene Ontology (GO) when provided in the patent
40 biology and life sciences experts support the GENESEQ editorial process

Simplify the complexity of biological sequences

GENESEQ ensures you are seeing the entire patent landscape surrounding the biological sequence under investigation. Manually curated and professionally annotated, it covers all biological sequences patented since 1981 from worldwide patent-issuing authorities – including WO, US, EP, JP, DE, IN, KR, and CN.

Never miss a patent with complete timely coverage

Uniquely, we go beyond what is available in electronic sequence submissions to bring you all sequences – even “hard-to-find” sequences in figures and tables so that you have the complete picture.

Nucleic acid sequences 10 or more bases in length
Amino acid sequences 4 or more residues in length
All PCR primers and probes of any length

Find context faster with annotated analysis Simplify the complexity of biological sequences Never miss a patent with complete timely coverage

On-demand webinar

Reducing the risk of missing relevant patents when searching for genetically engineered sequences

Watch this webinar to learn how new biological therapeutic approaches such as CAR-T cell therapies present challenges for patent searchers. We will illustrate how new tools, such as GENESEQ on SequenceBase and Derwent Innovation, can be used to reduce the margin for error during the patent search process, greatly increasing the speed and accuracy of your search for engineered sequences and the assessment of freedom to operate and actual infringement risk.